Michael Murphy, M.D.

Dr. Murphy is an Assistant Professor of Surgery in the section of Vascular Surgery. Dr. Murphy's laboratory performs numerous preclinical animal models, while clinically; he is an investigator on numerous adult stem cell trials in the area of critical limb ischemia. He was trained at Duke Medical University, Harvard, and Brigham and Women's Hospital.

Kyle Chan, Ph.D.

Dr. Chan is an accomplished scientist who started numerous biotechnology companies. He has served as Senior Director of Translational Research at Celgene corporation, leading development of numerous products through the FDA regulatory pathway. Dr. Chan has a Ph.D. from the University of Illinois at Champaign-Urbana and was also a Post-Doctoral Fellow at the University of California, San Diego.

Keith March, M.D., Ph.D.

Dr. March is Professor of Medicine, Physiology and Biomedical Engineering at the Indiana University School of Medicine and Krannert Institute of Cardiology. He is the Director of the Indiana Center for Vascular Biology and Medicine, and holds the Cryptic Masons Chair in Vascular Biology and Medicine. Dr. March has published more than 75 manuscripts and edited the first book dedicated to cardiovascular gene transfer. Dr. March invented and patented a device called Closer, a suture-mediated closure device that is used to close the arterial hole following a heart catheterization. The company that developed this technology was acquired in 1999 for $680 million, and the Closer approach is now used in 500,000 patients worldwide annually.

Nora Sarvetnick, Ph.D.

Dr. Sarvetnick joined the faculty at The Scripps Research Institute in 1990 as an Assistant Professor in the Department of Neuropharmacology. She was promoted to Associate Professor in 1994, and in 1996 was promoted to Associate Professor with Tenure in the Department of Immunology. In 2000 she became a full Professor in the Department of Immunology. Professor Sarvetnick graduated from Sarah Lawrence College in 1978 with a Bachelors Degree in Liberal Arts. She received her Ph.D. in Biochemistry in 1986, from The State University of New York, Stony Brook. She received a postdoctoral fellowship from the Muscular Dystrophy Association in 1986, and completed her postdoctoral studies in 1990 at Genentech Inc. in the laboratory of Dr. T.A. Stewart. She has over 170 peer reviewed publications and has received a number of awards, which include a Career Development Award from the Juvenile Diabetes Foundation (1990-1993) and a Multidisciplinary Diabetes Program Project Award from the Juvenile Diabetes Foundation (1995-2000). She has also twice been awarded an American Diabetes Association Mentor-Based Postdoctoral Fellowship Program Award (1996-2002 and 2005-2009). Her area of expertise is in Immunology and Type 1 Diabetes.